Addus HomeCare Corporation is a US-based provider of comprehensive in-home care services, primarily serving the elderly, chronically ill, and disabled individuals. Headquartered in Frisco, Texas, the company focuses on helping patients remain in their homes rather than facing institutionalization or hospitalization. Its core offerings include non-medical personal care, hospice, and home health services delivered across more than 20 states.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
1,422,530
1,154,599
1,058,651
951,120
Cost of Sales
960,656
779,578
718,775
651,381
Gross Profit
461,874
375,021
339,876
299,739
Selling, General & Administrative Expenses
306,847
258,800
234,794
216,942
Depreciation & Amortization Expenses
16,412
13,530
14,126
14,060
Operating Profit
138,615
102,691
90,956
68,737
Interest and Investment Income
2,442
4,394
1,476
341
Interest Expense
(13,612)
(7,732)
(11,106)
(8,907)
Total Non-Operating Income
(11,170)
(3,338)
(9,630)
(8,566)
Income Before Provision for Income Taxes
127,445
99,353
81,326
60,171
Provision for Income Taxes
31,535
25,755
18,810
14,146
Consolidated Net Income
95,910
73,598
62,516
46,025
Net Income Attributable to Common Shareholders
95,910
73,598
62,516
46,025
Basic EPS
5.31
4.33
3.91
2.90
Diluted EPS
5.22
4.23
3.83
2.84
Basic Weighted Average Shares Outstanding
18,053
17,006
15,996
15,861
Diluted Weighted Average Shares Outstanding
18,391
17,380
16,311
16,181
Shares Outstanding
18,518
18,148
16,227
16,128
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
81,617
98,911
64,791
79,961
Total Cash and Cash Equivalents
81,617
98,911
64,791
79,961
Accounts Receivable
151,695
122,880
115,499
125,501
Total Trade Receivables
151,695
122,880
115,499
125,501
Other Current Assets
36,179
38,591
19,714
17,345
Total Current Assets
269,491
260,382
200,004
222,807
Net Property, Plant & Equipment
68,711
72,051
69,444
60,162
Net Intangible Assets
102,410
109,643
91,983
72,188
Goodwill
996,696
970,558
662,995
582,837
Total Assets
1,437,308
1,412,634
1,024,426
937,994
Accounts Payable
16,832
27,176
26,183
22,092
Accrued Expenses
107,812
104,656
101,830
85,341
Current Portion of Leases
13,144
12,800
11,339
10,801
Other Current Liabilities
11,699
11,239
5,765
12,912
Total Current Liabilities
149,487
155,871
145,117
131,146
Long-Term Debt
120,959
218,443
124,132
131,772
Leases
37,259
41,883
39,711
35,479
Other Long-Term Liabilities
44,300
25,945
8,772
6,057
Total Long-Term Liabilities
202,518
286,271
172,615
173,308
Total Liabilities
352,005
442,142
317,732
304,454
Common Stock
18
18
16
16
Additional Paid-in Capital
612,945
594,044
403,846
393,208
Retained Earnings
472,340
376,430
302,832
240,316
Total Common Shareholders' Equity
1,085,303
970,492
706,694
633,540
Total Shareholders' Equity
1,085,303
970,492
706,694
633,540
Total Liabilities and Shareholders' Equity
1,437,308
1,412,634
1,024,426
937,994
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
95,910
73,598
62,516
46,025
Depreciation & Amortization
16,412
13,530
14,126
14,060
Share-Based Compensation Expense
16,424
11,165
10,319
10,625
Other Adjustments
20,764
16,614
4,400
6,620
Changes in Trade Receivables
(26,650)
22,137
15,666
20,592
Changes in Accounts Payable
(12,656)
(1,909)
2,025
2,514
Changes in Accrued Expenses
2,617
(5,131)
13,885
(5,536)
Changes in Other Operating Activities
(1,293)
(13,591)
(10,690)
10,210
Cash from Operating Activities
111,507
116,434
112,247
105,110
Capital Expenditure
(7,719)
(6,050)
(9,454)
(8,300)
Proceeds from Sale of Property, Plant & Equipment
15
29
15
—
Payments for Business Acquisitions
(31,581)
(353,946)
(109,797)
(98,290)
Proceeds from Business Divestments
6,785
5,357
—
—
Cash from Investing Activities
(32,500)
(354,610)
(119,236)
(106,590)
Issuance of Short-Term Debt
11,335
233,000
110,000
47,000
Repayments of Short-Term Debt
(110,000)
(136,353)
(118,500)
(137,000)
Net Issuance / (Repayments) of Short-Term Debt
(98,665)
96,647
(8,500)
(90,000)
Issuance of Common Shares
2,477
179,035
319
2,546
Net Issuance / (Repurchases) of Common Shares
2,477
179,035
319
2,546
Other Financing Activities
(113)
(3,386)
—
—
Cash from Financing Activities
(96,301)
272,296
(8,181)
(87,454)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash